Good Day BIO: Human capital mobility during COVID takes its toll on biotech

September 3, 2021
It’s the Friday before Labor Day—but we have an important exclusive on human capital mobility during COVID-19 and the detrimental impact on the U.S. biotech sector. Also, don’t miss our webinar (on September 14) on how we can improve diversity in biotech by leveraging…
BIO

It’s the Friday before Labor Day—but we have an important exclusive on human capital mobility during COVID-19 and the detrimental impact on the U.S. biotech sector. Also, don’t miss our webinar (on September 14) on how we can improve diversity in biotech by leveraging NIH’s SBIR and STTR programs. (687 words, 3 minutes, 26 seconds) 

Good Day BIO is taking a break for Labor Day on Monday, September 6. We will resume publication on Tuesday, September 7. Enjoy the long weekend.

 

Human capital mobility during COVID takes its toll on biotech

 
 

COVID-19 has caused major changes to work, travel, and learning—and the U.S. biotechnology sector has not been immune to these changes, we found in a new exclusive.

Many jobs in the U.S. held by foreign workers are unfulfilled, in large part because of COVID-19 and a series of restrictions issued on visa holders in June 2020. 

But foreign-born workers and innovators are key to the U.S. economy, and particularly the biotech sector. A few stats to know:

International students are returning to the U.S.—but more are needed. Foreign student enrollment has dropped by nearly 20% and resulted in $9.5 billion in lost revenue

These students are essential to STEM degree enrollment, with 22% of STEM degrees awarded to foreign students, including 54% of master’s degrees and 44% of doctorate degrees. Many of these students go on to work in the U.S. biotechnology sector. 

Anti-Asian sentiment and visa bans on Chinese STEM students have taken a toll.70% of all international students in the United States are from Asian countries, and 16% are from China—but a visa ban on certain Chinese STEM grad students remains in place.

Read: Why biotech must confront the epidemic of hate against AAPI communities 

So, now, many of these international students are deciding to study in their home countries—“a blow to U.S. competitiveness,” says NPR

Joe’s World: We at BIO believe that the biotechnology sector is at its most successful when opportunities for innovation know no borders and therefore are not limited by visa policies which disincentivize research and collaboration. – Joe Damond, BIO’s Deputy Chief Policy Officer and Executive Vice President of International Affairs 

Read the whole thing.

 

More News: 

Endpoints News: Inspired by the late Tachi Yamada, Jim Wilson launches new nonprofit targeting underserved ultra-rare diseases
“Jim Wilson, the famed gene therapy researcher, teamed up with the late Tachi Yamada and Braidwell’s Alex Karnal to launch the Institute for Life Changing Medicines.”  

Reuters: Corteva, Indigo Ag team up on carbon credit program for U.S. farmers
"Seeds and farm chemicals company Corteva Inc (CTVA.N) will partner with farm technology and services provider Indigo Ag to broaden its U.S. agricultural carbon credits program for the 2022 season, Corteva announced on Thursday."

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
 
 

Join BIO, the National Institute on Aging Office of Small Business Research, the National Center for Advancing Translational Sciences Small Business Program, and the National Institute on Alcohol Abuse and Alcoholism Small Business Program on Tuesday, September 14 at 1 PM ET for Improving Diversity in Biotech by Leveraging SBIR/STTR Opportunities, the final session in the 2021 NIH-BIO Summer Series.

BIO President and CEO Dr. Michelle McMurry Heath will lead this diversity-focused discussion and will highlight NIH’s SBIR and STTR programs across three NIH institutes and centers. The conversation will also feature the efforts and resources to improve the diversity of the research workforce.

Webinar Date: Tuesday, September 14, 2021

Webinar Time: 1 PM ET

Webinar Cost: Free! 

Click here to register now.

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
BIO Beltway Report
BIO Beltway Report
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

President Biden’s Friday: He will deliver remarks on the August jobs report, which is expected to show both strong hiring and some risk due to the COVID-19 Delta variant, according to CNBC. In the afternoon, he will travel to New Orleans for briefings with local leaders, and to inspect the damage of Hurricane Ida and meet with affected communities, per The Hill. While in Louisiana, he will give remarks at 3:35 PM ET regarding his administration’s response to Hurricane Ida.

What’s Happening on Capitol Hill: There is nothing scheduled in the House today ahead of the long weekend. Meanwhile, the Louisiana congressional delegation has come together in a letter to President Biden for an emergency-funding request in response to Hurricane Ida and are calling on Congress to pass emergency-funding legislation, according to Bloomberg. The Senate remains adjourned until Sept. 13.

 

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook